Recently, clinical-stage biopharmaceutical company Imara Inc. (“Imara”) announced that the first patient was dosed in the Phase 2b Forte clinical trial. The trial is
by Lauren Taylor from In The Cloud Copy Paroxysmal nocturnal hemoglobinuria (PNH) is a very rare disease of the blood in which the affected individuals
The road to diagnosis for a rare disease patient is often a long one. Countless doctors, appointments, and tests are typically needed to finally discover
According to a story from Vice World News, the Solanki family, who are residents of Ahmedabad, the largest city in India’s western state of Gujarat,
In a recent press release the US Food and Drug Administration (FDA) has officially approved remdesivir (marketed as Veklury) as a treatment for cases of
A study recently published in Cell Stem Cell has shown that using human stem cells in combination with medical chemistry can improve existing medications to treat genetic
© Copyright Patient Worthy
